Skip to main content

TA Associates Takes Majority Investment In IGEL

TA Associates is to make a majority investment in IGEL, a provider of the next-gen edge OS for cloud workspaces.

TA joins existing IGEL investor C. Melchers GmbH & Co. KG, which has been IGEL’s primary investor since its founding in 2001 and will maintain a significant equity interest in the company. After handing over the position of IGEL CEO to Jed Ayres last year, founder and former CEO of IGEL Heiko Gloge also remains as a minority stake holder and board member.

In addition to the naming of Veghte as IGEL Executive Chairman, Jonathan Meeks, Managing Director, TA Associates, and Stefan Dandl, Principal, TA Associates, will be added to the IGEL board. They will join existing IGEL board members Heiko Gloge, Managing Partner, and Nicolas Helms, Melchers Managing Partner.

“We believe IGEL is setting the benchmark for the new era of computing on the endpoint, and is primed to drive rapid and sustainable organic growth,” said Meeks. “With strong market leadership and a solid history of innovation and execution, IGEL is uniquely positioned to fulfill the ubiquitous need for secure, manageable cloud workspaces to support remote workers from anywhere. TA is pleased to be partnering with IGEL on this journey.”

“IGEL was founded based on a vision to help customers realize the benefits of a more secure, manageable and productive edge device infrastructure,” said Gloge. “Today, we are delivering on this vision with both passion and prowess.”

“After supporting IGEL since its founding in 2001 as principal investor, we are excited by the opportunities presented with TA´s investment in IGEL,” Helms stated. “We expect that the partnership with TA will provide IGEL with the experience, market access and resources to help propel IGEL through the next phase of growth.”


© The Sortino Group Ltd

All Rights Reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or scanning or otherwise, except under the terms of the Copyright, Designs and Patents Act 1988 or under the terms of a licence issued by the Copyright Licensing Agency or other Reprographic Rights Organisation, without the written permission of the publisher. For more information about reprints from AlphaWeek, click here.